Please use this identifier to cite or link to this item:
Appears in Collections:Management, Work and Organisation Journal Articles
Peer Review Status: Refereed
Title: Implementation of a metastatic malignancy of unknown primary origin service led by a palliative physician
Author(s): Brooks, David
Hughes, Philippa
Farrington, Clare
Bath, Peter A
McGregor, Mary
Ahmed, Wasim
Noble, Bill
Contact Email:
Keywords: Neoplasms
unknown primary
decision making
malignancy of undefined primary origin
palliative care
Issue Date: 2018
Date Deposited: 12-Oct-2021
Citation: Brooks D, Hughes P, Farrington C, Bath PA, McGregor M, Ahmed W & Noble B (2018) Implementation of a metastatic malignancy of unknown primary origin service led by a palliative physician. Hospital Practice, 46 (1), pp. 37-42.
Abstract: Background: Cancer of unknown primary is the fourth most common cause of cancer death in the United Kingdom. National guidance in 2010 recommended the establishment of a dedicated unknown primary team to facilitate targeted investigation and symptom control. A service development project was undertaken to identify those affected by malignancy of unknown origin and institute a pathway for coordinating their care led by a palliative physician. Method: In order to describe the patient population and illness trajectory and to assess the effect of the new pathway on the clinical outcomes we used a retrospective and prospective comparative case notes survey to identify the pre- and post-pathway population. This took place in secondary care. Inclusion criteria were patients with metastatic disease with no known primary; exclusion criteria were where the site of metastasis was so suggestive of a primary that it would be managed as per that disease process. 88 patients were included. Results: Mean age was 72.5 years. The mean survival time from presentation was 81.8 days. There was no difference pre or during pathway implementation in age, performance status or survival time. There was no reduction in the numbers referred for tumour directed therapy. There was a non-statistically significant reduction in the number who died in hospital during the pathway implementation. Conclusions: This study suggests having a metastatic malignancy of unknown primary origin service led by a palliative physician does not reduce the number referred for tumour directed therapy. It also adds evidence of the poor prognosis and thus the need for early palliative care input.
DOI Link: 10.1080/21548331.2018.1418140
Rights: This is an Accepted Manuscript of an article published by Taylor & Francis in Hospital Practice on 29/12/2017, available online:
Licence URL(s):

Files in This Item:
File Description SizeFormat 
Brooks-etal-HospitalPractice-2018.pdfFulltext - Accepted Version608.35 kBAdobe PDFView/Open

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.